FDA Urges More Accuracy On 'Latex Free' Med Supply Labels

Law360, Chicago (March 8, 2013, 2:28 PM EST) -- The U.S. Food and Drug Administration issued draft recommendations Friday pushing medical product manufacturers to stop labeling their products as "latex free" or "does not contain natural rubber latex," saying those phrases may be inaccurate and don't provide enough information for people with latex allergies.

The agency said that while those terms suggest that a product is completely free of natural rubber latex, or NRL, medical products can still become contaminated with NRL allergens during the packaging or manufacturing processes even when the products themselves are...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.